Provided by Tiger Fintech (Singapore) Pte. Ltd.

OmniAb, Inc.

1.50
+0.12008.70%
Post-market: 1.680.1800+12.00%19:56 EDT
Volume:1.43M
Turnover:2.10M
Market Cap:183.50M
PE:-2.54
High:1.52
Open:1.39
Low:1.35
Close:1.38
Loading ...

Director Steven Love Reports Acquisition of Common Shares in OmniAb Inc

Reuters
·
15 May

OmniAb Inc : Leerink Partners Raises Target Price to $10.00 From $7.00

THOMSON REUTERS
·
14 May

OmniAb (OABI) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
13 May

Craig-Hallum Keeps Their Buy Rating on OmniAb (OABI)

TIPRANKS
·
13 May

OmniAb Price Target Maintained With a $6.00/Share by Benchmark

Dow Jones
·
12 May

RBC Capital Remains a Buy on OmniAb (OABI)

TIPRANKS
·
09 May

OmniAb Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

OmniAb Q1 EPS $(0.17) Misses $(0.16) Estimate, Sales $4.15M Miss $4.49M Estimate

Benzinga
·
09 May

OmniAb Inc: Affirms Guidance for 2025 Revenue to Be in Range of $20 Mln to $25 Mln

THOMSON REUTERS
·
09 May

OmniAb Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
07 May

OmniAb, Veraxa Biotech Partner on Solid Tumor Drug Discovery Program

MT Newswires Live
·
06 May

VERAXA Biotech Enters Co-discovery Alliance with OmniAb for a Novel Bispecific Antibody Drug Conjugate Program

GlobeNewswire
·
06 May

OmniAb to Participate in Five Upcoming Investor Conferences

Business Wire
·
01 May

BRIEF-OmniAb Announces Two New Appointments To Its Board Of Directors

Reuters
·
21 Apr

OmniAb Announces Two New Appointments to Its Board of Directors

THOMSON REUTERS
·
21 Apr

OmniAb Announces Two New Appointments to its Board of Directors

Business Wire
·
21 Apr

OmniAb to Report First Quarter 2025 Financial Results on May 8

Business Wire
·
14 Apr

RBC Capital Sticks to Their Buy Rating for OmniAb (OABI)

TIPRANKS
·
03 Apr

Analyst Forecasts Just Became More Bearish On OmniAb, Inc. (NASDAQ:OABI)

Simply Wall St.
·
29 Mar

OmniAb Is Maintained at Outperform by RBC Capital

Dow Jones
·
27 Mar